99 related articles for article (PubMed ID: 27512000)
21. Expression of estrogen receptors (α, β), cyclooxygenase-2 and aromatase in normal endometrium and endometrioid cancer of uterus.
Knapp P; Chabowski A; Błachnio-Zabielska A; Walentowicz-Sadłecka M; Grabiec M; Knapp PA
Adv Med Sci; 2013; 58(1):96-103. PubMed ID: 23625281
[TBL] [Abstract][Full Text] [Related]
22. Mucin 1, Thomsen-Friedenreich expression and galectin-1 binding in endometrioid adenocarcinoma: an immunohistochemical analysis.
Mylonas I; Mayr D; Walzel H; Shabani N; Dian D; Kuhn C; Kunze S; Jeschke U; Friese K
Anticancer Res; 2007; 27(4A):1975-80. PubMed ID: 17649808
[TBL] [Abstract][Full Text] [Related]
23. [Expression and clinical significance of ADAM19 in endometrial carcinoma].
Ou Qz; Zhang Y; Yu L; Dong Y; Zhu C; Liao Qp
Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Apr; 40(2):165-9. PubMed ID: 18458692
[TBL] [Abstract][Full Text] [Related]
24. Prognostic significance of overexpression of p53 in uterine endometrioid adenocarcinomas with an analysis of nuclear grade.
Urabe R; Hachisuga T; Kurita T; Kagami S; Kawagoe T; Matsuura Y; Shimajiri S
J Obstet Gynaecol Res; 2014 Mar; 40(3):812-9. PubMed ID: 24246002
[TBL] [Abstract][Full Text] [Related]
25. Molecular profile of grade 3 endometrioid endometrial carcinoma: is it a type I or type II endometrial carcinoma?
Alvarez T; Miller E; Duska L; Oliva E
Am J Surg Pathol; 2012 May; 36(5):753-61. PubMed ID: 22498825
[TBL] [Abstract][Full Text] [Related]
26. Expression of gonadal steroid receptors in the ovaries of post-menopausal women with malignant or benign endometrial pathology: a pilot study.
Panoulis K; Christantoni E; Pliatsika P; Anagnostis P; Goulis DG; Kondi-Pafiti A; Armeni E; Augoulea A; Triantafyllou N; Creatsa M; Lambrinoudaki I
Gynecol Endocrinol; 2015; 31(8):613-7. PubMed ID: 26036714
[TBL] [Abstract][Full Text] [Related]
27. Progesterone receptor negativity is an independent risk factor for relapse in patients with early stage endometrioid endometrial adenocarcinoma.
Huvila J; Talve L; Carpén O; Edqvist PH; Pontén F; Grénman S; Auranen A
Gynecol Oncol; 2013 Sep; 130(3):463-9. PubMed ID: 23777659
[TBL] [Abstract][Full Text] [Related]
28. BAG-1 expression in normal endometrium, endometrial hyperplasia and endometrial cancer.
Song JY; Kim JW; Lee JK; Lee NW; Yeom BW; Kim SH; Lee KW
Acta Obstet Gynecol Scand; 2008; 87(8):862-7. PubMed ID: 18704778
[TBL] [Abstract][Full Text] [Related]
29. Molecular Analysis of Mixed Endometrioid and Serous Adenocarcinoma of the Endometrium.
Lawrenson K; Pakzamir E; Liu B; Lee JM; Delgado MK; Duncan K; Gayther SA; Liu S; Roman L; Mhawech-Fauceglia P
PLoS One; 2015; 10(7):e0130909. PubMed ID: 26132201
[TBL] [Abstract][Full Text] [Related]
30. The use of an immunocytochemical double-labeling staining can display the distribution of Bcl-2/Ki-67 cells in endometrial adenocarcinomas as well as in normal endometrium.
Mourtzikou A; Kosmas K; Marouga A; Stamouli M; Pouliakis A; Karakitsos P
Clin Lab; 2012; 58(1-2):133-44. PubMed ID: 22372356
[TBL] [Abstract][Full Text] [Related]
31. Postmenopausal status, hypertension and obesity as risk factors for malignant transformation in endometrial polyps.
Giordano G; Gnetti L; Merisio C; Melpignano M
Maturitas; 2007 Feb; 56(2):190-7. PubMed ID: 16963204
[TBL] [Abstract][Full Text] [Related]
32. Haptoglobin expression in endometrioid adenocarcinoma of the uterus.
Nabli H; Tuller E; Sharpe-Timms KL
Reprod Sci; 2010 Jan; 17(1):47-55. PubMed ID: 19801537
[TBL] [Abstract][Full Text] [Related]
33. Proliferative activity in postmenopausal endometrium: the lurking potential for giving rise to an endometrial adenocarcinoma.
Sivridis E; Giatromanolaki A
J Clin Pathol; 2004 Aug; 57(8):840-4. PubMed ID: 15280405
[TBL] [Abstract][Full Text] [Related]
34. Immunohistochemical expression of core 2 β1,6-N-acetylglucosaminyl transferase 1 (C2GnT1) in endometrioid-type endometrial carcinoma: a novel potential prognostic factor.
Miyamoto T; Suzuki A; Asaka R; Ishikawa K; Yamada Y; Kobara H; Nakayama J; Shiozawa T
Histopathology; 2013 Jun; 62(7):986-93. PubMed ID: 23617619
[TBL] [Abstract][Full Text] [Related]
35. Matrix metalloproteinases 2 and 9, E-cadherin, and beta-catenin expression in endometriosis, low-grade endometrial carcinoma and non-neoplastic eutopic endometrium.
Shaco-Levy R; Sharabi S; Benharroch D; Piura B; Sion-Vardy N
Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):226-32. PubMed ID: 18295959
[TBL] [Abstract][Full Text] [Related]
36. [Relationship between the expression of dual specificity phosphatase-1 and the prognosis of endometrioid adenocarcinoma].
Gao BR; Yao YY; Chen YH; Li XP; Wang JL; Wei LH
Zhonghua Yi Xue Za Zhi; 2013 Aug; 93(31):2493-5. PubMed ID: 24300273
[TBL] [Abstract][Full Text] [Related]
37. IMMUNOHISTOCHEMISTRY IN ENDOMETRIAL HYPERPLASIA AND ENDOMETRIAL ADENOCARCINOMA.
Socolov D; Socolov R; Lupascu IA; Rugina V; Gabia O; Garauleanu DM; Carauleanu A
Rev Med Chir Soc Med Nat Iasi; 2016; 120(2):355-62. PubMed ID: 27483717
[TBL] [Abstract][Full Text] [Related]
38. Coordinate expression of Cdc25B and ER-alpha is frequent in low-grade endometrioid endometrial carcinoma but uncommon in high-grade endometrioid and nonendometrioid carcinomas.
Wu W; Slomovitz BM; Celestino J; Chung L; Thornton A; Lu KH
Cancer Res; 2003 Oct; 63(19):6195-9. PubMed ID: 14559803
[TBL] [Abstract][Full Text] [Related]
39. Expression of cyclin D1 in normal, hyperplastic and neoplastic endometrium and its correlation with Ki-67 and clinicopathological variables.
Ozuysal S; Oztürk H; Bilgin T; Filiz G
Arch Gynecol Obstet; 2005 Feb; 271(2):123-6. PubMed ID: 14740230
[TBL] [Abstract][Full Text] [Related]
40. Membrane expression of trail receptors DcR1 and DcR2 in the normal endometrium, endometrial atypical hyperplasia and endometrioid endometrial cancer.
Gottwald L; Pasz-Walczak G; Piekarski J; Szwalski J; Kubiak R; Spych M; Suzin J; Tyliński W; Sęk P; Jeziorski A
J Obstet Gynaecol; 2014 May; 34(4):346-9. PubMed ID: 24649804
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
